白云山子公司获复方余甘子利咽含片生产许可证

财中社12-20

财中社12月20日电白云山（600332/00874）发布关于子公司《药品生产许可证》变更的公告。公告指出，子公司奇星药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》，允许其委托白云山制药总厂生产复方余甘子利咽含片，许可证有效期至2025年9月21日。此次变更涉及的委托生产地址包括广州市番禺区南村镇七星岗及广东省揭西县环城东路36号，委托生产的有效期为3年。公告还提到，此次委托生产...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492443398?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-20 19:52","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492443398","market":"hk","top_or_hot":-1,"title":"白云山子公司获复方余甘子利咽含片生产许可证","media":"财中社","content":"<div>\n<p>财中社12月20日电白云山（600332/00874）发布关于子公司《药品生产许可证》变更的公告。公告指出，子公司奇星药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》，允许其委托白云山制药总厂生产复方余甘子利咽含片，许可证有效期至2025年9月21日。此次变更涉及的委托生产地址包括广州市番禺区南村镇七星岗及广东省揭西县环城东路36号，委托生产的有效期为3年。公告还提到，此次委托生产...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220210550ab872fba&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>白云山子公司获复方余甘子利咽含片生产许可证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n白云山子公司获复方余甘子利咽含片生产许可证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 19:52 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220210550ab872fba&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社12月20日电白云山（600332/00874）发布关于子公司《药品生产许可证》变更的公告。公告指出，子公司奇星药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》，允许其委托白云山制药总厂生产复方余甘子利咽含片，许可证有效期至2025年9月21日。此次变更涉及的委托生产地址包括广州市番禺区南村镇七星岗及广东省揭西县环城东路36号，委托生产的有效期为3年。公告还提到，此次委托生产...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220210550ab872fba&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220210550ab872fba&s=b","article_id":"2492443398","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220210550ab872fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492443398","pubTimestamp":1734695573,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"财中社12月20日电白云山 发布关于子公司《药品生产许可证》变更的公告。公告指出，子公司奇星药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》，允许其委托白云山制药总厂生产复方余甘子利咽含片，许可证有效期至2025年9月21日。整体来看，此次许可证的获得对公司当期业绩没有重大影响。2024年前三季度，白云山实现收入590.60亿元，归母净利润31.59亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600332":"白云山","BK1191":"制药","BK1521":"挪威政府全球养老基金持仓","00874":"白云山","BK1515":"抗疫概念","BK1606":"中医药概念","BK1197":"保健护理产品经销商"},"translate_title":"Baiyunshan subsidiary obtained the production license of compound emblica liyan lozenges","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600332":0.9,"00874":1},"content_text":"财中社12月20日电白云山（600332/00874）发布关于子公司《药品生产许可证》变更的公告。公告指出，子公司奇星药业近日获得广东省药品监督管理局核准签发的《药品生产许可证》，允许其委托白云山制药总厂生产复方余甘子利咽含片，许可证有效期至2025年9月21日。此次变更涉及的委托生产地址包括广州市番禺区南村镇七星岗及广东省揭西县环城东路36号，委托生产的有效期为3年。公告还提到，此次委托生产有助于公司优化资源配置，保持稳定的生产能力，以满足市场需求。整体来看，此次许可证的获得对公司当期业绩没有重大影响。2024年前三季度，白云山实现收入590.60亿元，归母净利润31.59亿元。文章来源：财中社原标题：白云山子公司获复方余甘子利咽含片生产许可证","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492443398"}